Max Su received his doctoral degree in biostatistics from the Harvard School of Public Health where he completed his dissertation entitled “Methods for the analysis of health-related quality-of-life endpoints in clinical trials”.   Dr. Su represents the cohort of biostatistical and measurement methodologists that will lead the field in new advances in methods for measuring patient-reported outcomes in a era of advancing information technology. Dr. Su has applied his technological and analytical skills to build Phase V’s innovative web-based systems.